Ceftazidime

C difficile risk
High
Oral Bioavailability
N/A
Cost
$30/day

Dosing

Defined criteria for use and/or important safety considerations. See below for more information.

1 - 2 g IV q8h

2 g IV q8h

CrCl > 50 mL/minCrCl 30 - 50 mL/minCrCl 10 - 30 mL/minCrCl < 10 mL/minNo renal adjustment required1 - 2 g IV q12h1 - 2 g IV q24h1 - 2 g IV q48h

2 g IV qHD

  • Give dose after dialysis

500 mg IV q24h

1 - 2 g IV q12h

General Information

Treatment or empiric therapy for presumed Pseudomonas infections

  • Poor activity for most Gram-positive microorganisms

  • Does not treat ESBL producing microorganisms

Antimicrobial class: 3rd generation Cephalosporin

Pregnancy category: B

Average serum half life: 2 hours

Biliary penetration: Moderate

CSF penetration: Therapeutic

Lung penetration: Therapeutic

Urine penetration: Therapeutic

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.